Zobrazeno 1 - 10
of 141
pro vyhledávání: '"J. A. I. Weigl"'
Autor:
Weichert S, Ihorst G, J. A. I. Weigl, Walther S, W. Puppe, Heinz-Josef Schmitt, J. Forster, Wasem S
Publikováno v:
Klinische Pädiatrie. 220:291-295
BACKGROUND: This study analyses the pathogens of acute lower respiratory tract infections (LRI) in children in a German community hospital over six years. Against this background the adoption of new diagnostic and therapeutic guidelines for the LRI m
Autor:
Claudius U. Meyer, Fred Zepp, Reinhard Berner, J. A. I. Weigl, Johannes Forster, Heinz J. Schmitt, Wolfram Puppe
Publikováno v:
European Journal of Pediatrics
Introduction Surveillance systems for acute respiratory infections (ARI) in children currently are often limited in terms of the panel of pathogens and the age range investigated or are only syndromic and at times only active in the winter season. Me
Publikováno v:
Klinische Pädiatrie. 217:259-267
Background Lower respiratory tract infections (LRI) inflict a high burden of disease in children worldwide. Longitudinal, descriptive epidemiological data on different forms of LRI are urgently needed to differentiate this burden, compare population-
Publikováno v:
Klinische Pädiatrie. 217:211-219
Background Elaborated data on the descriptive epidemiology of community-acquired pneumonia (CAP) are a prerequisite to estimate the impact of new vaccines. Patients and methods From July 1996 to June 2000, all children (0-16 years) admitted to one of
Autor:
Fred Zepp, J. Forster, W. Puppe, Reinhard Berner, Heinz-Josef Schmitt, J. A. I. Weigl, C. U. Meyer
Publikováno v:
Klinische Pädiatrie. 217:47-52
Background Passive immunization with palivizumab is expensive and requires considerable logistic effort. So far 5 monthly injections from November to March are recommended. The RSV season onset and its duration, however, shows considerable variation.
Publikováno v:
Klinische Pädiatrie. 216:7-15
BACKGROUND Duration of hospitalization is influenced by many factors. It is an important parameter for quality of care. So far it is unknown, whether respiratory syncytial virus (RSV) etiology itself contributes to the time in hospital. METHOD Childr
Publikováno v:
Epidemiology and Infection. 129:525-533
Since new vaccines and anti-viral drugs for influenza have become available, collation of actual and country-specific epidemiological data is essential. Since respiratory syncytial virus (RSV) is a well known paediatric airway pathogen and some epide
Publikováno v:
Infection. 30:186-192
Elaborate, long-term data on the rhythm, seasonality and severity of the yearly respiratory syncytial virus (RSV) epidemics in Germany are lacking.A longitudinal investigation was undertaken of children from birth to 16 years of age admitted with an
Publikováno v:
European Journal of Epidemiology. 18:431-439
An unmatched, hospital-based case-con- trol study was performed, to determine, whether re- spiratory syncytial virus (RSV) etiology in hospitalized young children can be predicted clinically. Children under 2 years of age admitted with a lower respir
Publikováno v:
European Journal of Clinical Microbiology and Infections Diseases. 20:0452-0459
Epidemiological data, especially population-based data, on respiratory syncytial virus (RSV)-related hospitalizations in Germany have been lacking to date. Since Palivizumab (Synagis, Abbott, USA) is already available and new vaccines for active immu